DrugIn clinical trials
Deramiocel
deramiocel
Allogeneic cardiosphere-derived cell therapy studied for Duchenne muscular dystrophy. Not a gene therapy. On 20 November 2026 the FDA issued a complete response letter: the application does not meet the standard for approval.
Also in the catalogue
- Sirolimus (rapamycin)Drug
- ColchicineDrug
- AtropineDrug
- LithiumDrug
- EmpagliflozinDrug
- DarolutamideDrug
Scales
Identifiers
- INN
- deramiocel
Details
- Status
- In clinical trials
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.